Literature DB >> 22890474

Candesartan prevents impairment of recall caused by repeated stress in rats.

Jan Józef Braszko1, Dominik Wincewicz, Piotr Jakubów.   

Abstract

RATIONALE: Deleterious effects of psychological stress on memory are increasingly important. Overexpression of the AT(1) angiotensin receptors in brain has been found to participate in several negative effects of chronic stress including hypertension and a cognitive impairment.
OBJECTIVE: In this study, we searched for the protective effects the AT(1) angiotensin receptor blockade with candesartan against the adverse effects of repeated stress on recall of aversively and appetitively motivated behaviours in rats.
METHODS: Two groups of male Wistar rats were repeatedly stressed by keeping them daily (2 h/21 days) in tight plastic tubes. The subjects of the group 1 received candesartan (0.1 mg/kg, orally) each day before the stressing procedure. The rats of the group 2 received vehicle. Another two groups of rats (3 and 4) receiving candesartan and vehicle, respectively, were appropriately handled but not stressed. Next day, after ending the repeated stress procedure, all rats were tested in two cognitive paradigms: inhibitory avoidance (IA) and object recognition (OR).
RESULTS: Stressed animals displayed decreased recall of the IA behaviour (p < 0.01) and decreased OR (p < 0.05). These effects were not seen in the animals stressed and concomitantly treated with candesartan. The auxiliary tests designed to control for the possible unspecific contribution of motor (open field) and emotional (elevated "plus" maze) effects of the experimental procedures to results of the cognitive tests showed no such contribution.
CONCLUSION: These data strongly suggest that the AT(1) angiotensin receptor blockade effectively counteracts deleterious effects of stress on recall of aversively and appetitively motivated memories in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890474      PMCID: PMC3537078          DOI: 10.1007/s00213-012-2829-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

Review 1.  Hypertension therapy and cardiovascular protection. Effects of angiotensin II receptor block with Valsartan.

Authors:  A Sestito
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-11       Impact factor: 3.507

2.  Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.

Authors:  Li-Juan Min; Masaki Mogi; Masachika Shudou; Fei Jing; Kana Tsukuda; Kousei Ohshima; Jun Iwanami; Masatsugu Horiuchi
Journal:  Hypertension       Date:  2012-03-26       Impact factor: 10.190

Review 3.  An overview of candesartan in clinical practice.

Authors:  Zeeshan Khawaja; Christopher S Wilcox
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-08

4.  Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors.

Authors:  Darren S Leong; José A Terrón; Alicia Falcón-Neri; Ines Armando; Takeshi Ito; Olaf Jöhren; Leonardo H Tonelli; Kwang-Lee Hoe; Jaun M Saavedra
Journal:  Neuroendocrinology       Date:  2002-04       Impact factor: 4.914

5.  Effects of angiotensin II and its receptor antagonists on motor activity and anxiety in rats.

Authors:  J J Braszko; A Kułakowska; M M Winnicka
Journal:  J Physiol Pharmacol       Date:  2003-06       Impact factor: 3.011

6.  Emotion-induced amnesia in rats: working memory-specific impairment, corticosterone-memory correlation, and fear versus arousal effects on memory.

Authors:  James C Woodson; Deric Macintosh; Monika Fleshner; David M Diamond
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

7.  Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin.

Authors:  Gustavo Baiardi; Claudia Bregonzio; Miroslava Jezova; Ines Armando; Juan M Saavedra
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 8.  Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities.

Authors:  J M Saavedra; H Ando; I Armando; G Baiardi; C Bregonzio; M Jezova; J Zhou
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

9.  Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.

Authors:  Michael Schupp; Jürgen Janke; Ronald Clasen; Thomas Unger; Ulrich Kintscher
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

10.  Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II.

Authors:  G Aguilera; W S Young; A Kiss; A Bathia
Journal:  Neuroendocrinology       Date:  1995-04       Impact factor: 4.914

View more
  10 in total

1.  Angiotensin II, a stress-related neuropeptide in the CNS, facilitates micturition reflex in rats.

Authors:  Shogo Shimizu; Takahiro Shimizu; Kumiko Nakamura; Youichirou Higashi; Motoaki Saito
Journal:  Br J Pharmacol       Date:  2018-08-09       Impact factor: 8.739

2.  Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice.

Authors:  Heba A Ahmed; Tauheed Ishrat
Journal:  J Alzheimers Dis Rep       Date:  2022-06-02

3.  Angiotensin II centrally induces frequent detrusor contractility of the bladder by acting on brain angiotensin II type 1 receptors in rats.

Authors:  Bunya Kawamoto; Shogo Shimizu; Takahiro Shimizu; Youichirou Higashi; Masashi Honda; Takehiro Sejima; Motoaki Saito; Atsushi Takenaka
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

Review 4.  Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It.

Authors:  Aswar Urmila; Patil Rashmi; Ghag Nilam; Bodhankar Subhash
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-11-30       Impact factor: 1.636

Review 5.  The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.

Authors:  Feng Chen; Yanting Chen; Yongxiang Wang; Qiongwei Ke; Lili Cui
Journal:  Transl Neurodegener       Date:  2022-09-11       Impact factor: 9.883

6.  Angiotensin type 1 receptor inhibition enhances the extinction of fear memory.

Authors:  Paul J Marvar; Jared Goodman; Sebastien Fuchs; Dennis C Choi; Sunayana Banerjee; Kerry J Ressler
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

Review 7.  The Brain AT2R-a Potential Target for Therapy in Alzheimer's Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics.

Authors:  Heba A Ahmed; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2020-06-12       Impact factor: 5.682

8.  Impact of Chronic Stress Protocols in Learning and Memory in Rodents: Systematic Review and Meta-Analysis.

Authors:  Pedro Silva Moreira; Pedro R Almeida; Hugo Leite-Almeida; Nuno Sousa; Patrício Costa
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

Review 9.  Within the Brain: The Renin Angiotensin System.

Authors:  LaDonya Jackson; Wael Eldahshan; Susan C Fagan; Adviye Ergul
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

10.  Evaluation of an angiotensin Type 1 receptor blocker on the reconsolidation of fear memory.

Authors:  Adam P Swiercz; Laxmi Iyer; Zhe Yu; Allison Edwards; N M Prashant; Bryan N Nguyen; Anelia Horvath; Paul J Marvar
Journal:  Transl Psychiatry       Date:  2020-10-27       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.